Shared Proteins and Pathways of Cardiovascular and Cognitive Diseases : Relation to Vascular Cognitive Impairment
One of the primary goals of systems medicine is the detection of putative proteins and pathways involved in disease progression and pathological phenotypes. Vascular cognitive impairment (VCI) is a heterogeneous condition manifesting as cognitive impairment resulting from vascular factors. The precise mechanisms underlying this relationship remain unclear, which poses challenges for experimental research. Here, we applied computational approaches like systems biology to unveil and select relevant proteins and pathways related to VCI by studying the crosstalk between cardiovascular and cognitive diseases. In addition, we specifically included signals related to oxidative stress, a common etiologic factor tightly linked to aging, a major determinant of VCI. Our results show that pathways associated with oxidative stress are quite relevant, as most of the prioritized vascular cognitive genes and proteins were enriched in these pathways. Our analysis provided a short list of proteins that could be contributing to VCI: DOLK, TSC1, ATP1A1, MAPK14, YWHAZ, CREB3, HSPB1, PRDX6, and LMNA. Moreover, our experimental results suggest a high implication of glycative stress, generating oxidative processes and post-translational protein modifications through advanced glycation end-products (AGEs). We propose that these products interact with their specific receptors (RAGE) and Notch signaling to contribute to the etiology of VCI.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Journal of proteome research - 23(2024), 2 vom: 02. Feb., Seite 560-573 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zeylan, Melisa E [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.02.2024 Date Revised 13.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1021/acs.jproteome.3c00289 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367431971 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367431971 | ||
| 003 | DE-627 | ||
| 005 | 20240313234119.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240123s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acs.jproteome.3c00289 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1326.xml |
| 035 | |a (DE-627)NLM367431971 | ||
| 035 | |a (NLM)38252700 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zeylan, Melisa E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Shared Proteins and Pathways of Cardiovascular and Cognitive Diseases |b Relation to Vascular Cognitive Impairment |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.02.2024 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a One of the primary goals of systems medicine is the detection of putative proteins and pathways involved in disease progression and pathological phenotypes. Vascular cognitive impairment (VCI) is a heterogeneous condition manifesting as cognitive impairment resulting from vascular factors. The precise mechanisms underlying this relationship remain unclear, which poses challenges for experimental research. Here, we applied computational approaches like systems biology to unveil and select relevant proteins and pathways related to VCI by studying the crosstalk between cardiovascular and cognitive diseases. In addition, we specifically included signals related to oxidative stress, a common etiologic factor tightly linked to aging, a major determinant of VCI. Our results show that pathways associated with oxidative stress are quite relevant, as most of the prioritized vascular cognitive genes and proteins were enriched in these pathways. Our analysis provided a short list of proteins that could be contributing to VCI: DOLK, TSC1, ATP1A1, MAPK14, YWHAZ, CREB3, HSPB1, PRDX6, and LMNA. Moreover, our experimental results suggest a high implication of glycative stress, generating oxidative processes and post-translational protein modifications through advanced glycation end-products (AGEs). We propose that these products interact with their specific receptors (RAGE) and Notch signaling to contribute to the etiology of VCI | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a cardiovascular diseases | |
| 650 | 4 | |a cognitive diseases | |
| 650 | 4 | |a crosstalk | |
| 650 | 4 | |a network medicine | |
| 650 | 4 | |a oxidative stress | |
| 650 | 4 | |a protein–protein interaction networks | |
| 650 | 4 | |a systems biology | |
| 650 | 4 | |a vascular cognitive impairment | |
| 700 | 1 | |a Senyuz, Simge |e verfasserin |4 aut | |
| 700 | 1 | |a Picón-Pagès, Pol |e verfasserin |4 aut | |
| 700 | 1 | |a García-Elías, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Tajes, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz, Francisco J |e verfasserin |4 aut | |
| 700 | 1 | |a Oliva, Baldomero |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia-Ojalvo, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Barbu, Eduard |e verfasserin |4 aut | |
| 700 | 1 | |a Vicente, Raul |e verfasserin |4 aut | |
| 700 | 1 | |a Nattel, Stanley |e verfasserin |4 aut | |
| 700 | 1 | |a Ois, Angel |e verfasserin |4 aut | |
| 700 | 1 | |a Puig-Pijoan, Albert |e verfasserin |4 aut | |
| 700 | 1 | |a Keskin, Ozlem |e verfasserin |4 aut | |
| 700 | 1 | |a Gursoy, Attila |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of proteome research |d 2002 |g 23(2024), 2 vom: 02. Feb., Seite 560-573 |w (DE-627)NLM124173470 |x 1535-3907 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2024 |g number:2 |g day:02 |g month:02 |g pages:560-573 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.jproteome.3c00289 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2024 |e 2 |b 02 |c 02 |h 560-573 | ||